EU/US business group to tackle counterfeiting:
This article was originally published in Clinica
The fight against counterfeiting, a key concern to the new EU member states when it comes to medical device trade, is one of the priority areas for the Trans-Atlantic Business Dialogue as it continues its efforts to promote EU/US economic ties. Other priority areas highlighted at its meeting on June 25 were: open trade and security, intellectual property rights and capital markets and international accounting standards.
You may also be interested in...
CEO breaks down to Scrip how the Hong Kong-based company managed its way through the coronavirus outbreak in China, saying improvisation was critical.
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.